To elucidate the molecular mechanism by which miR-129-2 exerts its inhibitory effect on glioma cells, we predicted potential targets of miR-129-2 and focused on HMGB1 considering the involvement of HMGB1 in the pathogenesis of many human cancers. Here, HMGB1 is linked to cancer.